Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 25 10:37AM ET
7.27
Dollar change
-0.02
Percentage change
-0.27
%
IndexRUT P/E- EPS (ttm)-0.97 Insider Own41.87% Shs Outstand43.91M Perf Week-9.01%
Market Cap463.83M Forward P/E- EPS next Y-1.98 Insider Trans19.45% Shs Float37.09M Perf Month-2.68%
Income-45.08M PEG- EPS next Q-0.31 Inst Own59.90% Short Float8.68% Perf Quarter-4.09%
Sales0.00M P/S- EPS this Y-54.67% Inst Trans72.24% Short Ratio6.83 Perf Half Y79.95%
Book/sh3.62 P/B2.01 EPS next Y-52.10% ROA-24.56% Short Interest3.22M Perf Year119.64%
Cash/sh3.56 P/C2.04 EPS next 5Y- ROE-26.75% 52W Range2.18 - 13.68 Perf YTD59.78%
Dividend Est.- P/FCF- EPS past 5Y48.33% ROI-19.15% 52W High-46.86% Beta1.01
Dividend TTM- Quick Ratio17.99 Sales past 5Y0.00% Gross Margin- 52W Low233.49% ATR (14)0.66
Dividend Ex-Date- Current Ratio17.99 EPS Y/Y TTM20.14% Oper. Margin0.00% RSI (14)40.20 Volatility11.22% 8.41%
Employees42 Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price22.35
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-83.99% Payout- Rel Volume0.47 Prev Close7.29
Sales Surprise- EPS Surprise-10.66% Sales Q/Q- EarningsMay 09 BMO Avg Volume471.41K Price7.27
SMA20-14.87% SMA50-6.37% SMA20019.98% Trades Volume47,580 Change-0.27%
Date Action Analyst Rating Change Price Target Change
Apr-03-24Initiated Leerink Partners Outperform $25
Nov-17-23Upgrade Citigroup Neutral → Buy $4.50
Oct-19-22Initiated Guggenheim Buy $12
Feb-15-22Downgrade William Blair Outperform → Mkt Perform
Feb-10-21Initiated JMP Securities Mkt Outperform
Feb-01-21Initiated William Blair Outperform $29
May-30-24 04:05PM
May-22-24 11:25AM
May-21-24 07:39AM
May-20-24 04:05PM
May-09-24 01:55PM
07:00AM Loading…
07:00AM
Mar-20-24 01:32PM
Mar-14-24 09:53PM
05:32PM
04:05PM
Mar-11-24 04:05PM
Mar-06-24 04:05PM
Feb-20-24 01:47PM
Feb-19-24 01:48PM
Feb-16-24 04:20PM
06:15AM Loading…
Feb-14-24 06:15AM
Feb-13-24 04:18PM
Feb-12-24 07:00AM
Nov-14-23 07:00AM
Nov-01-23 04:05PM
Oct-03-23 04:05PM
Aug-31-23 04:05PM
Aug-10-23 07:00AM
Aug-07-23 09:22AM
Jul-25-23 09:59AM
07:00AM
Jul-17-23 04:05PM
Jun-21-23 04:05PM
May-15-23 07:00AM
Mar-28-23 04:05PM
07:00AM Loading…
Mar-14-23 07:00AM
Feb-07-23 04:05PM
Nov-21-22 04:05PM
Nov-10-22 07:00AM
Nov-07-22 04:05PM
Oct-20-22 08:00AM
Oct-19-22 04:05PM
Sep-16-22 01:00PM
Sep-14-22 07:04AM
07:01AM
Aug-11-22 04:05PM
Jul-28-22 04:05PM
Jun-28-22 08:00AM
06:05AM
Jun-02-22 08:00AM
May-19-22 08:00AM
May-12-22 07:00AM
Apr-29-22 06:27AM
Apr-13-22 10:40AM
Mar-25-22 07:00AM
Feb-16-22 11:57AM
Feb-14-22 04:01PM
Jan-19-22 06:53AM
Nov-22-21 07:00AM
Nov-20-21 08:40AM
Nov-15-21 07:00AM
Nov-12-21 07:00AM
Sep-16-21 08:00AM
Sep-02-21 04:01PM
Aug-22-21 10:12AM
Aug-19-21 07:00AM
Aug-12-21 07:00AM
Aug-09-21 08:48AM
Jul-23-21 12:00PM
Jul-08-21 04:01PM
Jun-11-21 07:00AM
Jun-05-21 07:55PM
Jun-02-21 10:56PM
Jun-01-21 04:55AM
May-29-21 10:59PM
May-25-21 05:41PM
May-21-21 09:18AM
May-20-21 04:31PM
May-11-21 07:00AM
May-10-21 04:05PM
Mar-04-21 07:00AM
Mar-01-21 03:54AM
Feb-18-21 04:01PM
Dec-16-20 07:23PM
Dec-15-20 08:00AM
Dec-08-20 07:30AM
Nov-13-20 08:00AM
Nov-10-20 08:00AM
Oct-14-20 10:18PM
Oct-13-20 08:00AM
Sep-21-20 09:58AM
Sep-10-20 08:00AM
Sep-01-20 12:47PM
Aug-11-20 07:00AM
Aug-04-20 08:00AM
Jul-28-20 08:00AM
Jul-20-20 04:15PM
May-29-20 04:05PM
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flynn James EDirectorFeb 16 '24Buy8.744,290,61737,499,9936,151,406Feb 16 02:37 PM
Hamilton Thomas EdwardDirectorFeb 16 '24Buy8.7457,208499,998564,798May 31 04:56 PM
THOMAS FRANK EDirectorFeb 14 '24Buy11.002,00022,0002,000Feb 15 04:21 PM
Shankar GopiChief Development OfficerDec 07 '23Buy3.735,00018,6625,000Dec 08 04:08 PM